Skip to content

Drug interactions

Exemestane + Tucatinib

Severity: Moderate

Exemestane and Tucatinib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Tucatinib is a strong CYP3A inhibitor and may raise exemestane concentrations. Exemestane has a wide therapeutic margin, so clinically significant toxicity is unlikely but possible.

What this interaction means in plain words

Exemestane and Tucatinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Exemestane belongs to Oncology; Tucatinib belongs to Oncology.

Evidence level: Low

Why it happens

CYP3A4 inhibition by tucatinib reduces exemestane clearance.

What to do

No empiric exemestane dose change is needed. Monitor for adverse effects such as fatigue, arthralgia and hot flashes.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Exemestane and Tucatinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Exemestane with Tucatinib?

MediHelp rates the interaction as moderate. Exemestane and Tucatinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Tucatinib is a strong CYP3A inhibitor and may raise exemestane concentrations. Exemestane has a wide therapeutic margin, so clinically significant toxicity is unlikely but possible.

How serious is the interaction between Exemestane and Tucatinib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No empiric exemestane dose change is needed. Monitor for adverse effects such as fatigue, arthralgia and hot flashes.

What other medicines interact with Exemestane?

MediHelp also lists interactions of Exemestane with, for example, Bazedoxifene-conjugated estrogens, Desogestrel-ethinyl estradiol, Estradiol. The full list is on the Exemestane page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in